GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
CLEVELAND — For occupational therapist Jennifer O'Hanlon at the Cleveland Sight Center, every day brings an opportunity to ...
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
Our film critic reviews the animated category’s candidates, which are playing at Coolidge Corner, and picks his choice to win ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
With the charming Friendly Neighborhood Spider-Man swinging onto our screens as the 13th Disney+ Marvel show in just four ...
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...
Japanese technology company SoftBank Group Corp. reported a 369.2 billion yen, or $2.4 billion, loss for the fiscal third ...
After a devastating election loss and three weeks into a whirlwind Trump administration, what most animates a leaderless ...
I first met Wincy Ong in the buzzing world of advertising and PR, a place where creativity and storytelling intertwine with ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
The HHSC Blindness Education, Screening and Treatment (BEST) Program is spreading awareness about vision loss during Low Vision Awareness Month in February. The BEST program works with Prevent ...